Ethyl-(o-hydroxy-phenyl)-sulfon | 29549-71-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: Ethyl-(o-hydroxy-phenyl)-sulfon
• 英文别名: Phenol, o-(ethylsulfonyl)-；2-ethylsulfonylphenol
• CAS: 29549-71-1
• 化学式: C₈H₁₀O₃S
• 分子量: 186.232
• InChiKey: KHHGIIHTPAPSIV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  62.8
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  Ethyl-(o-hydroxy-phenyl)-sulfon 、 氯化苄 在 potassium carbonate 作用下， 以 丙酮 为溶剂， 生成 Aethyl-<2-benzyloxy-phenyl>-sulfon
  参考文献：
  名称：

  Heterocyclic Vinyl Ethers. XVII. Benzo-1,4-oxathiadiene-2-aldehyde, 2-Methylbenzo-1,4-oxathiadiene and 3-Methylbenzo-1,4-oxathiadiene¹

  摘要：

  DOI：

  10.1021/jo01071a016
• 作为产物：
  描述：

  2-羟基苯硫酚 在 双氧水 作用下， 以 乙酸酐 、 溶剂黄146 为溶剂， 生成 Ethyl-(o-hydroxy-phenyl)-sulfon
  参考文献：
  名称：

  邻-羟基苯基烷基硫化物，-亚砜和-砜：合成和光谱学研究

  摘要：

  已通过NMR，IR和UV光谱合成和研究了标题化合物，并特别注意了H键。这些化合物似乎以螯合形式存在。此外，在亚砜的情况下，已经通过计算机监控的混合物分析对电子轰击质谱进行了详细研究。

  DOI：

  10.1016/s0040-4020(01)93093-5

文献信息

• [EN] 1H-PYRROLO[2,3-c]PYRIDIN-7(6H)-ONES AND PYRAZOLO[3,4-c]PYRIDIN-7(6H)-ONES AS INHIBITORS OF BET PROTEINS<br/>[FR] 1H-PYRROLO [2,3-C] PYRIDINE -7(6H)-ONES ET PYRAZOLO[3,4-C]PYRIDINE-7(6H)-ONES EN TANT QU'INHIBITEURS DE PROTÉINES BET
  申请人：INCYTE CORP

  公开号：WO2015164480A1

  公开（公告）日：2015-10-29

  The present invention relates to substituted pyrrolopyridinones and substituted pyrazolopyridinones which are inhibitors of BET proteins such as BRD2, BRD3, BRD4, and BRD-t and are useful in the treatment of diseases such as cancer.

  本发明涉及取代吡咯吡啶酮和取代吡唑吡啶酮，它们是BET蛋白（如BRD2、BRD3、BRD4和BRD-t）的抑制剂，并且在治疗癌症等疾病中具有用途。
• IONIC LIQUID SYSTEMS
  申请人：The Procter & Gamble Company

  公开号：US20160177222A1

  公开（公告）日：2016-06-23

  The present invention relates to an ionic liquid system for enhanced delivery and/or deposition of a perfume raw material onto a substrate, particularly fabric, hard surfaces, soft surfaces, skin, or hair. The invention also relates to consumer products comprising the new ionic liquid systems, and processes for making and methods of using such ionic liquid systems and consumer products.

  本发明涉及一种离子液体系统，用于增强香水原料在基底上的传递和/或沉积，特别是织物、硬表面、软表面、皮肤或头发。该发明还涉及包含新离子液体系统的消费产品，以及制造和使用这种离子液体系统和消费产品的方法。
• Novel 2-Heteroaryl-Substituted Benzimidazole Derivative
  申请人：Nonoshita Katsumasa

  公开号：US20080070928A1

  公开（公告）日：2008-03-20

  A glucokinase activator is provided; and a remedy and/or a preventive for diabetes, or a remedy and/or a preventive for diabetes such as retinopathy, nephropathy, neurosis, ischemic cardiopathy, arteriosclerosis, and further a remedy and/or a preventive for obesity are provided. A glucokinase activator characterized by containing a 2-heteroaryl-substituted benzimidazole derivative of a general formula (I-0) or its pharmaceutically-acceptable salt: [in the formula, X represents a carbon atom or a nitrogen atom; X 1 , X 2 , X 3 and X 4 each independently represent a carbon atom or a nitrogen atom; the ring A represents a 5- or 6-membered nitrogen-containing aromatic hetero ring of a formula (II): (in the formula, X represents a carbon atom or a nitrogen atom); R 1 represents an aryl, etc.; R 2 represents a hydroxy, etc.; R 3 represents a —C 1-6 alkyl, etc.; R 4 represents a —C 1-6 alkyl, etc.; X 5 represents —O—, etc.; a indicates an integer of 1, 2 or 3; q indicates an integer of from 0 to 2; m indicates an integer of from 0 to 2].

  提供了一种葡萄糖激酶激活剂；提供了糖尿病的治疗和/或预防，或者提供了糖尿病的治疗和/或预防，例如视网膜病变、肾病、神经病、缺血性心脏病、动脉硬化，以及肥胖症的治疗和/或预防。葡萄糖激酶激活剂的特征在于包含通式（I-0）的2-杂环芳基取代苯并咪唑衍生物或其药学上可接受的盐：[在公式中，X表示碳原子或氮原子；X1、X2、X3和X4分别独立地表示碳原子或氮原子；环A表示公式（II）的5-或6-成员含氮芳香杂环：（在公式中，X表示碳原子或氮原子）；R1表示芳基等；R2表示羟基等；R3表示-C1-6烷基等；R4表示-C1-6烷基等；X5表示-O-等；a表示1、2或3的整数；q表示0到2的整数；m表示0到2的整数]。
• Phenylquinoline compositions for treatment of ocular disorders and conditions
  申请人：The Board of Regents of the University of Oklahoma

  公开号：US11337968B2

  公开（公告）日：2022-05-24

  Compositions containing a phenylquinoline derivative compound having peroxisome proliferator-activated receptor a (PPARα) agonistic activity, and methods of their use in enhancing PPARα activity in retinal cells, and in treating ocular disorders or conditions, such as but not limited to retinal inflammation, retinal neovascularization, retinal vascular leakage, retinopathy of prematurity, diabetic retinopathy, age-related macular degeneration, and diabetic macular edema are disclosed.

  本发明公开了含有具有过氧化物酶体增殖激活受体 a（PPARα）激动活性的苯基喹啉衍生物化合物的组合物，以及将其用于增强视网膜细胞中 PPARα 活性和治疗眼部疾病或病症的方法，例如但不限于视网膜炎症、视网膜新生血管、视网膜血管渗漏、早产儿视网膜病变、糖尿病视网膜病变、老年性黄斑变性和糖尿病黄斑水肿。
• Agonists of peroxisome proliferator-activated receptor alpha and methods of use
  申请人：The Board of Regents of the University of Oklahoma

  公开号：US11447452B2

  公开（公告）日：2022-09-20

  Benzyl derivative compounds having peroxisome proliferator-activated receptor α (PPARα) agonistic activity, compositions containing such compounds, and methods of their use in enhancing PPARα activity for treating diseases and/or conditions involving inflammation and/or angiogenesis, particularly ocular diseases and/or conditions such as but not limited to retinal inflammation, retinal neovascularization, retinal vascular leakage, retinopathy of prematurity, diabetic retinopathy, age-related macular degeneration, and diabetic macular edema are disclosed.

  本发明公开了具有过氧化物酶体增殖激活受体α（PPARα）激动活性的苄基衍生物化合物、含有此类化合物的组合物，以及将其用于增强 PPARα 活性以治疗涉及炎症和/或血管生成的疾病和/或病症的方法，特别是眼部疾病和/或病症，如但不限于视网膜炎症、视网膜新生血管、视网膜血管渗漏、早产儿视网膜病变、糖尿病视网膜病变、老年性黄斑变性和糖尿病黄斑水肿。